Gastrocrom and Zofran drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Gastrocrom (cromolyn sodium) and Zofran (ondansetron hydrochloride). Common drug interactions include abdominal pain among females and malignant neoplasm progression among males.

The phase IV clinical study analyzes what interactions people have when they take Gastrocrom and Zofran. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Gastrocrom?

Gastrocrom has active ingredients of cromolyn sodium. eHealthMe is studying from 255 Gastrocrom users. Check the latest studies of Gastrocrom.

What is Zofran?

Zofran has active ingredients of ondansetron hydrochloride. It is often used in nausea. eHealthMe is studying from 94,987 Zofran users. Check the latest studies of Zofran.

On Jul, 14, 2026

24 people who take Gastrocrom and Zofran together, and have interactions are studied.

Gastrocrom and Zofran drug interactions.

What are the common drug interactions of Gastrocrom and Zofran, by gender? *:

female:

Abdominal pain
Acute sinusitis
Asthenia (weakness)
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Cystitis (inflammation of the wall of the bladder)
Decreased appetite
Depression
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Head injury
Increased appetite

male:

Malignant neoplasm progression (cancer tumour came back)
Sepsis (a severe blood infection that can lead to organ failure and death)

What are the common drug interactions of Gastrocrom and Zofran, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Malignant neoplasm progression (cancer tumour came back)
Sepsis (a severe blood infection that can lead to organ failure and death)
Abdominal pain upper
Asthma
Chest discomfort
Cough
Dyspnoea (difficult or laboured respiration)
Headache (pain in head)
Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
Urticaria (rash of round, red welts on the skin that itch intensely)

20-29:

n/a

30-39:

Anaphylactic reaction (serious allergic reaction)

40-49:

Anxiety
Abdominal pain upper
Cough
Decreased appetite
Depression
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Head injury
Increased appetite
Memory impairment
Migraine (headache)

50-59:

Injection site pain
Injection site swelling
Injection site warmth
Neck pain
Pruritus (severe itching of the skin)
Pyrexia (fever)
Sepsis (a severe blood infection that can lead to organ failure and death)
Thyroid mass
Upper respiratory tract infection
Visual impairment

60+:

Anaphylactic reaction (serious allergic reaction)
Angioedema (rapid swelling of the dermis)

What are the existing conditions these people have? *

Asthma: 8 people, 33.33%
Idiopathic Urticaria (allergic reactions, presence of hives with unknown cause): 7 people, 29.17%
Autoimmune Disorder (a condition in which the immune system attacks the body's normal substances and tissue): 5 people, 20.83%
Stress And Anxiety: 3 people, 12.50%
Muscle Spasms (muscle contraction): 3 people, 12.50%
Itching: 3 people, 12.50%
Drowsiness: 3 people, 12.50%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 3 people, 12.50%
Wheezing (a high-pitched whistling sound made while you breath): 2 people, 8.33%
Sleep Disorder: 2 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Gastrocrom and Zofran?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously